Expanding Canadian Medicare to Include a National Pharmaceutical Benefit While Controlling Expenditures: Possible Lessons From Israel

Health Economics, Policy and Law - United Kingdom
doi 10.1017/s174413311700041x
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Expanding the Breadth of Medicare: Learning From Australia

Health Economics, Policy and Law
Health Policy
2018English

Proportion of Decedents’ Expenditures Among Recent Reductions in Medicare Expenditures

JAMA Internal Medicine
Internal Medicine
2018English

In: State Variations in Medicare Expenditures

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1997English

A Projection for Pharmaceutical Expenditures in Japan

Iryo To Shakai
2000English

New Development: Expanding Public Service Value to Include Dis/Value

Public Money and Management
ManagementBusinessPublic AdministrationSociologyPolitical ScienceAccounting
2020English

Prosecuting Medicare Fraudsters: Lessons Learned From Recent Litigation

Journal of Leadership, Accountability and Ethics
2017English

Changes in Initial Expenditures for Benign Prostatic Hyperplasia Evaluation in the Medicare Population: A Comparison to Overall Medicare Inflation

Journal of Urology
Urology
2012English

The Response of Drug Expenditures to Non-Linear Contract Design: Evidence From Medicare Part D

2013English

Is Expanding Medicare Coverage Cost-Effective?

BMC Health Services Research
Health Policy
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy